Secure transplantation by tissue purging using photodynamic therapy to eradicate malignant cells

The field of photodynamic therapy (PDT) for treating various malignant neoplasms has been given researchers' attention due to its ability to be a selective and minimally invasive cancer therapy strategy. The possibility of tumor cell infection and hence high recurrence rates in cancer patients...

Full description

Saved in:
Bibliographic Details
Published in:Journal of photochemistry and photobiology. B, Biology Biology, 2022-09, Vol.234, p.112546-112546, Article 112546
Main Authors: Moghassemi, Saeid, Dadashzadeh, Arezoo, de Azevedo, Ricardo Bentes, Amorim, Christiani A.
Format: Article
Language:English
Subjects:
Autografts
Cancer
Cancer therapy
Cell death
Hematopoietic stem cells
Nanomedicine
Neoplasia
Neoplasms
Oxygen
Photodynamic therapy
Photoinactivation
Photosensitizer
Purging
Reactive oxygen species
Stem cells
Tissue purging
Tissues
Transplantation
Tumor cells
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The field of photodynamic therapy (PDT) for treating various malignant neoplasms has been given researchers' attention due to its ability to be a selective and minimally invasive cancer therapy strategy. The possibility of tumor cell infection and hence high recurrence rates in cancer patients tends to restrict autologous transplantation. So, the photodynamic tissue purging process, which consists of selective photoinactivation of the malignant cells in the graft, is defined as a compromising strategy to purify contaminated tissues before transplantation. In this strategy, the direct malignant cells' death results from the reactive oxygen species (ROS) generation through the activation of a photosensitizer (PS) by light exposure in the presence of oxygen. Since new PS generations can effectively penetrate the tissue, PDT could be an ideal ex vivo tissue purging protocol that eradicates cancer cells derived from various malignancies. The challenge is that the applied pharmacologic ex vivo tissue purging should efficiently induce tumor cells with minor influence on normal tissue cells. This review aims to provide an overview of the current status of the most effective PDT strategies and PS development concerning their potential application in ex vivo purging before hematopoietic stem cell or ovarian tissue transplantation. •PDT as a selective and minimally invasive strategy is affordable and widely available.•PDT can be used to inhibit cell infection and destroy cancer cells.•Safe autologous transplantation can be possible using ex vivo PDT-purging.•PDT is an option for ex vivo purging before hematopoietic stem cell transplantation.•Ex vivo PDT has a great potential to be used before ovarian tissue transplantation.
ISSN:1011-1344
1873-2682
DOI:10.1016/j.jphotobiol.2022.112546